We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

91 hedge funds and large institutions have $246M invested in Cytokinetics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $3.51M | Put options by funds: $1.35M

62% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 21

3% less capital invested

Capital invested by funds: $254M → $246M (-$8.08M)

4% less funds holding

Funds holding: 95 → 91 (-4)

22% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 18

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
91
Holders Change
-4
Holders Change %
-4.21%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
14
Increased
34
Reduced
21
Closed
18
Calls
$3.51M
Puts
$1.35M
Net Calls
+$2.17M
Net Calls Change
+$1.73M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.3M
2
State Street
State Street
Massachusetts
+$3.65M
3
Millennium Management
Millennium Management
New York
+$3.26M
4
Invesco
Invesco
Georgia
+$900K
5
Two Sigma Investments
Two Sigma Investments
New York
+$822K

Top Sellers

1
EC
EcoR1 Capital
California
-$13.5M
2
ACA
Avoro Capital Advisors
New York
-$4.78M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.17M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.1M
5
IHM
Iguana Healthcare Management
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
ZIM
51
Zacks Investment Management
Illinois
$237K +$269K +25,787 New
AQR Capital Management
52
AQR Capital Management
Connecticut
$228K +$65.9K +6,311 +34%
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$225K -$11.7K -1,117 -4%
CG
54
Cutler Group
California
$205K +$156K +14,909 +198%
NFA
55
Nationwide Fund Advisors
Ohio
$202K – – –
GW
56
GW & Wade
Massachusetts
$184K – – –
CLOS
57
Compagnie Lombard Odier SCmA
Switzerland
$184K +$209K +20,000 New
SSA
58
Schonfeld Strategic Advisors
New York
$184K +$209K +20,000 New
FAM
59
Fortaleza Asset Management
Illinois
$184K +$42.6K +4,085 +26%
AIG
60
American International Group
New York
$179K +$303 +29 +0.1%
Wells Fargo
61
Wells Fargo
California
$144K +$7.93K +760 +5%
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
$137K +$1.67K +160 +1%
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$123K +$139K +13,356 New
PPA
64
Parametric Portfolio Associates
Washington
$121K -$10.4K -996 -7%
Simplex Trading
65
Simplex Trading
Illinois
$118K +$131K +12,539 +3,823%
RJA
66
Raymond James & Associates
Florida
$105K -$10.4K -1,000 -8%
LCM
67
Leisure Capital Management
California
$102K -$637 -61 -0.5%
Lido Advisors
68
Lido Advisors
California
$97K – – –
Barclays
69
Barclays
United Kingdom
$96K +$27.8K +2,666 +35%
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
$93K -$33.7K -3,227 -24%
DS
71
DRW Securities
Illinois
$92K +$104K +10,000 New
EMG
72
Ellington Management Group
Connecticut
$92K +$104K +10,000 New
Bank of America
73
Bank of America
North Carolina
$48K +$10.5K +1,005 +24%
Legal & General Group
74
Legal & General Group
United Kingdom
$43K – – –
UBS Group
75
UBS Group
Switzerland
$40K +$18.6K +1,786 +71%
1 2
3
4 5

CYTK Hedge Fund Activity: Q3 2016 in Review

91 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2016, worth a combined $246M — down 3.2% from $254M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CYTK and 14 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 34 added.

The largest buyer was Fidelity Investments, adding an estimated $18.3M. The largest seller was EcoR1 Capital, cutting an estimated $13.5M.

  • 91 institutional investors held Cytokinetics (CYTK) as of Q3 2016, down from 95 in Q2 2016.
  • Funds reported $246M of Cytokinetics stock for Q3 2016, down 3.2% quarter-over-quarter.
  • 14 funds opened new Cytokinetics positions in Q3 2016 and 18 closed out, a net change of -4 holders.
  • The largest Cytokinetics buyer in Q3 2016 was Fidelity Investments, an estimated $18.3M added.
  • The largest Cytokinetics seller in Q3 2016 was EcoR1 Capital, an estimated $13.5M sold.

Based on aggregated 13F filings for Q3 2016.